Does TIPRANAVIR Cause Lung neoplasm malignant? 74 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Lung neoplasm malignant have been filed in association with TIPRANAVIR (Aptivus). This represents 18.4% of all adverse event reports for TIPRANAVIR.
74
Reports of Lung neoplasm malignant with TIPRANAVIR
18.4%
of all TIPRANAVIR reports
0
Deaths
74
Hospitalizations
How Dangerous Is Lung neoplasm malignant From TIPRANAVIR?
Of the 74 reports, 74 (100.0%) required hospitalization.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIPRANAVIR. However, 74 reports have been filed with the FAERS database.
What Other Side Effects Does TIPRANAVIR Cause?
Cholelithiasis (218)
Schizophrenia (217)
Nausea (216)
Pneumonia (216)
Vomiting (216)
Hypomania (151)
Hepatotoxicity (148)
Psychotic disorder (148)
Blood bilirubin increased (147)
Condition aggravated (147)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which TIPRANAVIR Alternatives Have Lower Lung neoplasm malignant Risk?
TIPRANAVIR vs TIRBANIBULIN
TIPRANAVIR vs TIROFIBAN
TIPRANAVIR vs TIRZEPATIDE
TIPRANAVIR vs TISAGENLECLEUCEL
TIPRANAVIR vs TISLELIZUMAB